These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35781820)

  • 1. Adverse drug reaction reporting quality among different health professionals and the contribution of clinical pharmacists: A pilot study.
    Yan J; Xiong X; Shen J; Huang T
    J Clin Pharm Ther; 2022 Nov; 47(11):1768-1774. PubMed ID: 35781820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporting, Monitoring, and Handling of Adverse Drug Reactions in Australia: Scoping Review.
    Fossouo Tagne J; Yakob RA; Dang TH; Mcdonald R; Wickramasinghe N
    JMIR Public Health Surveill; 2023 Jan; 9():e40080. PubMed ID: 36645706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time series analysis of using the PDCA method combined with the Teach-back method to improve spontaneous reports of adverse drug reactions in a grade IIIA hospital in China.
    Li B; Jiang L; Liao L; Chen Y; Xu Z; Wu N; Chen H; Wu P; Liu T
    Eur J Clin Pharmacol; 2024 Mar; 80(3):383-393. PubMed ID: 38151504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
    Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region.
    Irujo M; Beitia G; Bes-Rastrollo M; Figueiras A; Hernández-Díaz S; Lasheras B
    Drug Saf; 2007; 30(11):1073-82. PubMed ID: 17973543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain.
    Sweis D; Wong IC
    Drug Saf; 2000 Aug; 23(2):165-72. PubMed ID: 10945377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profile of adverse drug reaction reports in South Africa: An analysis of VigiBase® for the year 2017.
    Steyn H
    S Afr Med J; 2023 Jun; 113(6):26-33. PubMed ID: 37278262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADR in Journals: Are They Translated into Regulatory Frameworks?
    Kolupoti A; Chakraborty A; Shahistha K
    Curr Drug Saf; 2022; 17(1):34-39. PubMed ID: 34151768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reactions of non-opioid and opioid analgesics reported to Croatian national authority from 2007 to 2014.
    Sunara P; Krnic D; Puljak L
    Acta Med Acad; 2017 Nov; 46(2):94-104. PubMed ID: 29338273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Analysis of Information Provided in German Adverse Drug Reaction Reports Sent by Physicians, Pharmacists and Consumers.
    Christ P; Dubrall D; Schmid M; Sachs B
    Drug Saf; 2023 Dec; 46(12):1363-1379. PubMed ID: 37987966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian study.
    Leone R; Moretti U; D'Incau P; Conforti A; Magro L; Lora R; Velo G
    Drug Saf; 2013 Apr; 36(4):267-76. PubMed ID: 23475583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motivation and Knowledge of Portuguese Community Pharmacists Towards the Reporting of Suspected Adverse Reactions to Medicines: A Cross-Sectional Survey.
    Ferreira-da-Silva R; Alves JM; Vieira C; Silva AM; Marques J; Morato M; Polónia JJ; Ribeiro-Vaz I
    J Community Health; 2023 Apr; 48(2):295-308. PubMed ID: 36401737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Retrospective Review of Serious Adverse Drug Reaction Reports in the Nigerian VigiFlow Database from September 2004 to December 2016.
    Ogar CK; Abiola A; Yuah D; Ibrahim A; Oreagba IA; Amadi EC; Adeyeye MC; Oshikoya KA
    Pharmaceut Med; 2019 Apr; 33(2):145-157. PubMed ID: 31933250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community pharmacists' views on adverse drug reactions reporting in Malaysia: a pilot study.
    Ting KN; Stratton-Powell DM; Anderson C
    Pharm World Sci; 2010 Jun; 32(3):339-42. PubMed ID: 20336371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of hospitals that report adverse drug reactions: Results of a nationwide survey in Japan.
    Tsuchiya M; Kikuchi D; Hatakeyama S; Tasaka Y; Uchikura T; Funakoshi R; Obara T
    J Clin Pharm Ther; 2022 Aug; 47(8):1240-1248. PubMed ID: 35362208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran.
    Vessal G; Mardani Z; Mollai M
    Pharm World Sci; 2009 Apr; 31(2):183-7. PubMed ID: 19116770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does spontaneous adverse drug reactions' reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre.
    Nicol C; Moulis F; Bondon-Guitton E; Durrieu G; Montastruc JL; Bagheri H
    Therapie; 2019 Oct; 74(5):521-525. PubMed ID: 31029402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The quality of spontaneous adverse drug reaction reports from the pharmacovigilance centre in western China.
    Niu R; Xiang Y; Wu T; Zhang Z; Chen Y; Feng B
    Expert Opin Drug Saf; 2019 Jan; 18(1):51-58. PubMed ID: 30574811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse Drug Reaction Monitoring and Reporting Among Physicians and Pharmacists in Pakistan: A Cross-sectional Study.
    Nisa ZU; Zafar A; Zafar F; Pezaro S; Sher F
    Curr Drug Saf; 2020; 15(2):137-146. PubMed ID: 32338223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.